NIFTY 50▼24,749.85
-221.45 (-0.89%)
SENSEX▼81,006.61
-494.75 (-0.61%)
NIFTY BANK▼51,288.80
-512.25 (-0.99%)
TATA MOTORS▼891.60
-15.85 (-1.75%)
SUZLON ENERGY▼73.01
-2.04 (-2.72%)
TATA STEEL▼152.40
-2.84 (-1.83%)
INDIAN RAILWAY FINANCE CORP▼149.12
-1.64 (-1.09%)
TATA POWER▼450.20
-10.25 (-2.23%)
RAIL VIKAS NIGAM▲489.60
10.00 (2.09%)
RELIANCE INDUSTRIES▲2,712.85
4.70 (0.17%)
VODAFONE IDEA▼9.05
-0.24 (-2.58%)
RELIANCE POWER▼41.74
-2.20 (-5.01%)
ZOMATO▼270.55
-3.70 (-1.35%)
INDIAN RENEWABLE ENERGY▼217.71
-3.40 (-1.54%)
ADANI POWER▼609.10
-16.70 (-2.67%)
YES BANK▼20.90
-0.25 (-1.18%)
STATE BANK OF INDIA▲811.05
5.60 (0.70%)
NHPC▼84.95
-3.04 (-3.45%)
HDFC BANK▼1,673.15
-26.65 (-1.57%)
JIO FIN SERVICES LTD▼329.15
-4.50 (-1.35%)
OLA ELECTRIC MOBILITY LTD▼87.57
-1.60 (-1.79%)
BHARAT ELECTRONICS▼284.55
-1.15 (-0.40%)
INDIAN OIL CORP▼164.28
-4.11 (-2.44%)
GTL INFRA▼2.24
-0.02 (-0.88%)
ADANI PORT & SEZ▼1,394.70
-9.10 (-0.65%)
MRF▼1,29,811.75
-682.05 (-0.52%)
JAIPRAKASH POWER VENTURES▼19.90
-1.25 (-5.91%)
INDIAN RAILWAY TOURISM CORP▼871.75
-20.85 (-2.34%)
BALAXI PHARMA LTD Share Price
BALAXI
₹97.25+₹3.95 (4.23%) TodayLast updated on 17 Oct, 2024 | 15:29 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹94.10 | Close₹93.30 |
Circuit range₹111.96 - ₹74.64 | Day range₹94.10 - ₹98.94 | Year range₹79.99 - ₹151.45 |
Volume38,490 | Avg. traded₹96.71 | Revenue (12m)₹241 Crs |
BALAXI PHARMA LTDBalaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across Latin America and Africa. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It has a portfolio across multiple therapeutic segments, stock & sell models, and supplies branded and generic medicines. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents and Laxative. Its subsidiary is Balaxi Global DMCC, Dubai.
BALAXI PHARMA LTD Key indicators
52 week high₹151.45 | 52 week low₹79.99 | P/E ratio12.01 |
P/B ratio2.55 | ROE3.66% | ROCE6.08% |
Dividend yield-- | Debt/Equity ratio0.12 | EPS3.35 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin11.04% | Net profit margin5.2% |
ROE3.66% | ROA2.57% |
ROCE6.08% |
Learn more
BALAXI PHARMA LTD Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Wed, Oct 16 2024 | ₹94.30 | ₹93.30 | -0.27% |
Tue, Oct 15 2024 | ₹96.50 | ₹93.55 | -2.53% |
Mon, Oct 14 2024 | ₹97.60 | ₹95.98 | -1.14% |
Fri, Oct 11 2024 | ₹97.19 | ₹97.09 | -0.10% |
Thu, Oct 10 2024 | ₹97.90 | ₹97.19 | -0.25% |
Wed, Oct 9 2024 | ₹101.00 | ₹97.43 | -0.14% |
Tue, Oct 8 2024 | ₹97.00 | ₹97.57 | -0.09% |
Mon, Oct 7 2024 | ₹103.90 | ₹97.66 | -1.93% |
Events
Corporate actions
Split • 2:10
Ex date 29 May 2024
Dividend • ₹0.5/share
Ex date 01 Jul 2022
Learn more